Weight loss drugs such as Mounjaro offer huge potential to tackle soaring obesity globally but are currently only available to one in 10 of those who need them, the World Health Organization has said
Mounjaro : Brand name tirzepatide FDA-approved for diabetes, but widely used off-label for weight loss due to its powerful dual GIP/GLP-1 mechanism
Other Benefits: Lower testosterone levels, improved menstrual cycles, better blood sugar control, and reduced cardiovascular risks
Blood glucose levels were measured using Accu-Chek Aviva glucose monitors (Roche, Indianapolis IN)
Lillys SURPASS-CVOT , providing the first CV-outcomes data for tirzepatide, albeit in T2D patients with established atherosclerotic CV disease and in H2H comparison vs
Long-Term (12+ months) Some people may stay on GLP-1s long term to maintain results , especially if appetite returns or weight begins to creep back